Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 18Lymphoma, B-Cell, Marginal Zone 6Stomach Neoplasms 4Neoplasms, Plasma Cell 4Lymphoma 4Dyspepsia 3Recurrence 2Peptic Ulcer 2Gastritis 2Skin Neoplasms 1Pseudomyxoma Peritonei 1Prostatic Neoplasms 1Persistence of Infection With Helicobacter Pylori 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, B-Cell 1Infections 1Helicobacter Infections 1Familial primary gastric lymphoma 1Chemotherapy Effect 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Appendiceal Neoplasms 1

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Recurrence × Clarithromycin × Clear all
NCT01516606 2022-08-12

HD-K

IRCCS San Raffaele

Phase 2 Completed
23 enrolled
Lymphoid

Lymphoma, Recurrence

NCT02986451 2018-08-14

Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma

Sun Yat-sen University

Phase 2 Withdrawn
Plasma cell

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡